SCHEMBL14723340

SCHEMBL14723340

COc1cccc(C(=O)c2cnc(NC3CCN(S(C)(=O)=O)CC3)nc2N)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 18/20 0.71
CDK4 P11802 17/20 0.71
CCND1 P24385 17/20 0.71
CDK2 P24941 17/20 0.71
CASK O14936 1/20 0.63
ROCK2 O75116 1/20 0.63
CDKL5 O76039 1/20 0.63
STK10 O94804 1/20 0.63
CDK14 O94921 1/20 0.63
ABL1 P00519 1/20 0.63
EGFR P00533 1/20 0.63
MAK P20794 1/20 0.63
CDK11B P21127 1/20 0.63
TTK P33981 1/20 0.63
CLK1 P49759 1/20 0.63
CLK2 P49760 1/20 0.63
CLK3 P49761 1/20 0.63
GSK3A P49840 1/20 0.63
GSK3B P49841 1/20 0.63
CDK7 P50613 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4346548 0.89 CDK1 (0.73) CDK1CDK4CCND1CDK2CASK
SCHEMBL3519637 0.87 CDK2 (0.75) CDK1CDK4CCND1CDK2CASK
SCHEMBL4351116 0.86 CDK1 (0.82) CDK1CDK4CCND1CDK2CASK
SCHEMBL3835508 0.86 CDK1 (0.51) CDK1CDK4CCND1CDK2CASK
SCHEMBL4352687 0.85 CDK1 (0.88) CDK1CDK4CCND1CDK2CASK
SCHEMBL4360999 0.84 CDK1 (0.77) CDK1CDK4CCND1CDK2CASK
SCHEMBL4352519 0.83 CDK1 (1.00) CDK1CDK4CCND1CDK2CASK
SCHEMBL4361250 0.82 CDK2 (0.70) CDK1CDK4CCND1CDK2CASK
SCHEMBL4350749 0.82 CDK2 (0.73) CDK1CDK4CCND1CDK2CASK
SCHEMBL4352663 0.82 CDK2 (0.75) CDK1CDK4CCND1CDK2CASK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2747755-A1 CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA Lead Discovery Center GmbH (DE) 2014-07-02 EP claimed
WO-2013026874-A1 CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA LEAD DISCOVERY CENTER GMBH (DE) 2013-02-28 WO claimed